Fingerprint
Dive into the research topics of 'Greatly reduced risk of EBV reactivation in Rituximab-experienced recipients of Alemtuzumab-conditioned allogeneic HSCT'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Greatly reduced risk of EBV reactivation in Rituximab-experienced recipients of Alemtuzumab-conditioned allogeneic HSCT
David Burns, Shabeeha Rana, Emma Martin, Sandeep Nagra, Janice Ward, Husam Osman, Andrew Bell, Paul Moss, Nigel H Russell, Charles Craddock, Christopher Fox, Sridhar Chaganti
Research output: Contribution to journal › Article › peer-review
20
Citations
(Scopus)
228
Downloads
(Pure)